Skip to main content
Clinical Trials/IRCT2014020816524N1
IRCT2014020816524N1
Completed
Phase 2

Comparison of the Effect of Alfentanil and Remifentanil on QT Interval in Septoplasty with Local Epinephrine

Vice Chancellor for Research, Shiraz University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
QT Prolongation.
Sponsor
Vice Chancellor for Research, Shiraz University of Medical Sciences
Enrollment
80
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research, Shiraz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients with physical status class I \-II, based on the classification of the American Society of Anesthesiologists (ASA) and the age up to50 years undergoing septoplasty. Exclusion criteria: the use of any effective drug on QT interval in 14 days before surgery (TCA); beta antagonist, anti\-arrhythmic, the calcium channel blocker) ; QTc more than 440 m/s; The existence of branches blocks, arrhythmia (preexitation syndrome) ; Structural heart disease.; electrolyte imbalance; hyper or hypothyroid patients 7\. Extreme Obesity BMI 30 \>; Diabetic neuropathy; Any non\- sinus rhythm in EKG; A history of sensitivity to propofol, egg and soy.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials